Prostate Cancer Cells clone-27 Loss on Androgen-Regulated Transcription in Genome-Wide Impact of Androgen Receptor Trapped

The androgen receptor (AR) directs diverse biological processes through interaction with coregulators such as AR trapped clone-27 (ART-27). Our results show that ART-27 is recruited to AR-binding sites by chromatin immunoprecipitation analysis. In addition, the effect of ART-27 on genomewide transcription was examined. The studies indicate that loss of ART-27 enhances expression of many androgenregulated genes, suggesting that ART-27 inhibits gene expression. Surprisingly, classes of genes that are up-regulated upon ART-27 depletion include regulators of DNA damage checkpoint and cell cycle progression, suggesting that ART-27 functions to keep expression levels of these genes low. Consistent with this idea, stable reduction of ART-27 by short-hairpin RNA enhances LNCaP cell proliferation compared with control cells. The effect of ART-27 loss was also examined in response to the antiandrogen bicalutamide. Unexpectedly, cells treated with ART-27 siRNA no longer exhibited gene repression in response to bicalutamide. To examine ART-27 loss in prostate cancer progression, immunohistochemistry was conducted on a tissue array containing samples from primary tumors of individuals who were clinically followed and later shown to have either recurrent or nonrecurrent disease. Comparison of ART-27 and AR staining indicated that nuclear ART-27 expression was lost in the majority of AR-positive recurrent prostate cancers. Our studies show that reduction of ART-27 protein levels in prostate cancer may facilitate antiandrogen-resistant disease. [Cancer Res 2009;69(7):3140–7]

[1]  J. Nwachukwu,et al.  Transcriptional regulation of the androgen receptor cofactor androgen receptor trapped clone-27. , 2007, Molecular endocrinology.

[2]  S. Balk,et al.  Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. , 2007, Cancer research.

[3]  R. McGilvray,et al.  UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation , 2007, The FEBS journal.

[4]  Bianhong Zhang,et al.  UXT is a novel and essential cofactor in the NF-κB transcriptional enhanceosome , 2007, The Journal of cell biology.

[5]  G. Hager,et al.  Ligand-Specific Dynamics of the Androgen Receptor at Its Response Element in Living Cells , 2007, Molecular and Cellular Biology.

[6]  C. Cai,et al.  c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation , 2006, Oncogene.

[7]  M. Garabedian,et al.  The Cochaperone p23 Differentially Regulates Estrogen Receptor Target Genes and Promotes Tumor Cell Adhesion and Invasion , 2006, Molecular and Cellular Biology.

[8]  J. Wong,et al.  The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. , 2006, Molecular endocrinology.

[9]  J. Nwachukwu,et al.  First-trimester trophoblast cell model gene response to hypoxia. , 2006, American journal of obstetrics and gynecology.

[10]  C. Cai,et al.  SUMO-3 Enhances Androgen Receptor Transcriptional Activity through a Sumoylation-independent Mechanism in Prostate Cancer Cells* , 2006, Journal of Biological Chemistry.

[11]  M. Hengartner,et al.  URI-1 is required for DNA stability in C. elegans , 2006, Development.

[12]  H. Scher,et al.  Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Myles A Brown,et al.  Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. , 2005, Molecular cell.

[14]  Claudio N. Cavasotto,et al.  Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function. , 2005, Molecular endocrinology.

[15]  M. Ittmann,et al.  SRC-3 is required for prostate cancer cell proliferation and survival. , 2005, Cancer research.

[16]  A. Weiner,et al.  Software L 2 L : a simple tool for discovering the hidden significance in microarray expression data , 2005 .

[17]  B. Weissman,et al.  BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF , 2005, Molecular and Cellular Biology.

[18]  C. Morrissey,et al.  Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. , 2005, Clinical science.

[19]  S. Murakami,et al.  Subcellular Localization of RPB5-Mediating Protein and Its Putative Functional Partner , 2004, Molecular and Cellular Biology.

[20]  Guoying Liu,et al.  NetAffx Gene Ontology Mining Tool: a visual approach for microarray data analysis. , 2004, Bioinformatics.

[21]  S. Taneja,et al.  ART-27, an Androgen Receptor Coactivator Regulated in Prostate Development and Cancer* , 2004, Journal of Biological Chemistry.

[22]  R. Vessella,et al.  Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.

[23]  M. Vigneron,et al.  Control of Nutrient-Sensitive Transcription Programs by the Unconventional Prefoldin URI , 2003, Science.

[24]  D. Livingston,et al.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin , 2003, EMBO reports.

[25]  A. Bookout,et al.  Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways , 2003, Nuclear receptor signaling.

[26]  M. Cole,et al.  TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis , 2002, Oncogene.

[27]  Robert Tibshirani,et al.  Transcriptional programs activated by exposure of human prostate cancer cells to androgen , 2002, Genome Biology.

[28]  Y. Shang,et al.  Formation of the androgen receptor transcription complex. , 2002, Molecular cell.

[29]  J T Arnold,et al.  Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. , 2002, Endocrine-related cancer.

[30]  S. Taneja,et al.  Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. , 2002, Molecular biology of the cell.

[31]  Z. Ronai,et al.  TIP49b, a Regulator of Activating Transcription Factor 2 Response to Stress and DNA Damage , 2001, Molecular and Cellular Biology.

[32]  M. Shen,et al.  Molecular genetics of prostate cancer. , 2000, Genes & development.

[33]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[34]  L. Ossowski,et al.  Activation of Rb and decline in androgen receptor protein precede retinoic acid–induced apoptosis in androgen‐dependent LNCaP cells and their androgen‐independent derivative , 1999, Journal of cellular physiology.

[35]  T. Yamashita,et al.  RMP, a Novel RNA Polymerase II Subunit 5-Interacting Protein, Counteracts Transactivation by Hepatitis B Virus X Protein , 1998, Molecular and Cellular Biology.

[36]  J. Veldscholte,et al.  Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones , 1991, The Journal of Steroid Biochemistry and Molecular Biology.